(NYSE: EW) Edwards Lifesciences's forecast annual revenue growth rate of 8.95% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.7%.
Edwards Lifesciences's revenue in 2025 is $5,439,500,000.On average, 12 Wall Street analysts forecast EW's revenue for 2025 to be $3,417,932,432,100, with the lowest EW revenue forecast at $3,390,419,300,000, and the highest EW revenue forecast at $3,440,390,800,000. On average, 12 Wall Street analysts forecast EW's revenue for 2026 to be $3,748,870,748,500, with the lowest EW revenue forecast at $3,673,787,100,000, and the highest EW revenue forecast at $3,817,234,700,000.
In 2027, EW is forecast to generate $4,151,713,350,200 in revenue, with the lowest revenue forecast at $3,980,670,900,000 and the highest revenue forecast at $4,304,486,220,000.